Cleaner DuPont still needs industrial recovery

Sharper, but not simple

DuPont has become easier to understand. It spun off its Electronics business as Qnity in November 2025, then completed the Aramids divestiture on April 1, 2026. The Aramids sale brought about $1.2 billion in pre-tax cash proceeds, plus a $300 million note receivable and a common equity interest valued at $325 million.

The bull case is that DuPont can now focus on the better parts of the company. Healthcare & Water Technologies grew Q1 2026 sales to $806 million, up 6% year over year and 3% organically, meaning growth excluding currency and deal effects. Diversified Industrials also stopped getting worse, with $875 million of sales and flat organic sales.

The bear case has not gone away. Diversified Industrials is stable, but not yet growing. Construction markets are still weak, and DuPont remains tied to cyclical end markets like aerospace, auto, energy, and building materials.

Capital return helps, but the stock does not screen as cheap in Finn's model. The company announced plans for a $275 million accelerated share repurchase, and it still has room under a larger $2 billion authorization. Investors still need to see where the Aramids cash goes and what margins look like in the new two-segment company.

Special materials for hard jobs

DuPont makes engineered materials that customers use inside products where failure is costly. That includes medical packaging, biopharma materials, water purification, worker safety, aerospace parts, auto materials, energy applications, and building products.

The company makes money by selling specialized products that often need technical support and customer testing. That can create sticky demand, because customers do not change approved materials quickly in healthcare, water, or aerospace.

The model breaks when end markets slow or customers run down inventory. Construction is the current pressure point. Supply chain trouble can also hurt, as Q1 2026 Water Technologies was partly held back by logistics disruptions in the Middle East.

After the Qnity separation, DuPont received about $4.1 billion to $4.2 billion in cash and used it to cut debt, including about $4.0 billion of senior notes. The cleaner balance sheet supports dividends and buybacks, but the company still needs organic growth to justify investor confidence.

What DuPont sells now

Two businesses after the spin

Segment mix uses Q1 2026 net sales: $806 million for Healthcare & Water Technologies and $875 million for Diversified Industrials. This is a short-period view, so mix can move with seasonality and construction demand.

What could go wrong

In one breath